Clinical Trials - September 27, 2019
Patient recruitment in Oncopeptides trial completed
The company has announced that the last patient has been included in the OP-106 HORIZON phase 2 clinical study evaluating melflufen with dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM). Oncopeptides has previously communicated a target enrollment of 150 patients in the study before the end of September, which now has been achieved. Could potentially […]
Clinical Trials - September 26, 2019
Sigrid Therapeutics reports new results from their Proof of Concept STAR study
The company has reported the first results from their Proof of Concept STAR study in subjects with prediabetes or newly diagnosed type 2 diabetes. The company’s lead product, SiPore15, an orally administered non-absorbed medical device, demonstrated a 1,4 mmol/mol mean reduction in HbA1c, a key marker of glucose control (p=0.0391). SiPore15 showed no increased safety […]
Business Award - September 10, 2019
Umeå Biotech Incubator is Biotech Incubator of the Year 2019 in Scandinavia
Umeå Biotech Incubator, UBI, has been named Scandinavia’s best biotech incubator at the International Life Science Awards 2019. “Our goal is to be best in Europe, so this is definitely a step in the right direction,” says Jennie Ekbeck, CEO of Umeå Biotech Incubator. “We believe in pay it forward and always want to share […]
Uncategorized - September 10, 2019
Karolinska Institutet’s vice president relieved from her assignment
Karolinska Institutet’s Vice President Karin Dahlman-Wright has requested to be relieved from her assignment as vice president with immediate effect. Consequently, KI’s University Board (Konsistoriet) agreed to relieve her from the assignment at an extra meeting today. Reports of alleged scientific misconduct The decision follows reports of alleged scientific misconduct that were submitted to KI […]
Uncategorized - September 6, 2019
Karin Dahlman-Wright found guilty of misconduct in research
Karolinska Institutet’s Pro-Vice-Chancellor has been found guilty of misconduct in research by the Oredlighetsrådet at the University of Gothenburg. Karin Dahlman-Wright was accused of misconduct last year but since Karolinska Institutet found it improper to investigate the matter themselves it was given to the University of Gothenburg. Dahlman-Wright has been found guilty in one case. […]
Financing - September 5, 2019
Sigrid Therapeutics closes oversubscribed round of $1.6 million
The company has announced an equity financing round of USD 1.6 million, bringing total pre-launch funding to $9 million. The two times oversubscribed financing round was led by Joyance Partners, a US-based venture capital firm, and Pär Gellerfors, one of the founders of the biotechnology company BioArctic, listed on Nasdaq Stockholm. “Sigrid Therapeutics is an […]